[1]
X. Zhu, K. Stergiopoulos, and S. Wu, “Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis”, AO, vol. 48, no. 1, pp. 9–17, Jan. 2009.